Abbott, Laboratory Corporation of America Holdings, and Siemens Healthcare GmbH dominated the Thailand Clinical Laboratory Services Market in 2020

Thailand Clinical Laboratory Services Market is expected to grow with a CAGR of 6.2% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/thailand-clinical-laboratory-services-market

Thailand clinical laboratory services market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenarios.    

The major players dealing in the Thailand clinical laboratory services market are introducing a strong range of product providers, launching new products, and adopting strategic initiatives such as mergers, partnerships, and agreements. This helped companies to maximize sales with an enhanced product portfolio.

For instance,

  • In June 2021, Abbott announced it had received CE Mark and Health Canada approval for its Amplatzer Steerable Delivery Sheath, which is used with its market-leading Amplatzer Amulet Left Atrial Appendage (LAA) Occluder. Abbott's Amplatzer Amulet has long been the LAA occlusion device of choice in Europe and Canada to reduce the risk of stroke and eliminate the need for blood-thinning medication in patients with atrial fibrillation. This innovation advances the performance of companies Amplatzer Amulet device and offers patients a much-needed treatment option to help manage stroke risk from atrial fibrillation

Abbott is the dominating player in the Thailand clinical laboratory services market. The other key players in the market include Eurofins Scientific, Siemens Healthcare GmbH, Charles River Laboratories, Laboratory Corporation of America Holdings, Andalab Medical Laboratories, Brianet, Syneos Health, and SGS SA, among others.

Thailand Clinical Laboratory Services Market Abbott

Abbott was founded in the year 1888, and it has headquarters in Illinois, U.S. It has public ownership. The company engaged in creating breakthrough products– in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals– that help the community lead healthier lives and make a lasting impact on health. The company has business segments such as Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices under which Diagnostic Products are the market-focused segment. Core Laboratory, Molecular, Point of Care, and Rapid Diagnostics are the company's product categories under which Rapid Diagnostics is the market-focused category.

For instance,

  • In June 2021, Abbott announced it had received CE Mark and Health Canada approval for its Amplatzer Steerable Delivery Sheath, which is used with its market-leading Amplatzer Amulet Left Atrial Appendage (LAA) Occluder. Abbott's Amplatzer Amulet has long been the LAA occlusion device of choice in Europe and Canada to reduce the risk of stroke and eliminate the need for blood-thinning medication in patients with atrial fibrillation. This innovation advances the performance of companies Amplatzer Amulet device and offers patients a much-needed treatment option to help manage stroke risk from atrial fibrillation

The company has a wide presence across North America, South America, Europe, Asia-Pacific, Middle East, and South Africa. The company has various subsidiaries like Abbott Administration Inc(Delaware), Abbott Cardiovascular Systems Inc.(California), Abbott Home Infusion Services of New York, Inc. (New York), Abbott Laboratories (Puerto Rico) Incorporated, EAS Australia Pty Ltd(Australia), Abbott (Cambodia) LLC, Abbott Laboratories A/S(Denmark) among others.

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings has headquarters in North Carolina, U.S., and was founded in 1995. It has public ownership. The company focuses on improving health and lives by providing world-class diagnostics accelerating the availability of innovative medicines by using technology to deliver the best care for the patients and the clients. The company has various business segments such as Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD), amongst which Labcorp Diagnostics (Dx) is the market-focused segment.

The service categories are Provider Services, Research, Analysis Services, Lead Optimization, Product Testing, Manufacturing Support, Toxicology, Safety Assessment and Testing, Consulting and Partnering, Clinical Development, Informatics, Clinical Testing, Commercialization. Amongst it Clinical Testing, Provider Services are the market-focused categories.

For instance,

  • In December 2020, Laboratory Corporation of America, a leading global life sciences company that is focused on advancing health and guiding patient care decisions, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the Pixel by LabCorp COVID-19 Test Home Collection Kit to become the first to be available over the counter without requiring a prescription. With the first over-the-counter at-home collection kit ever authorized by the FDA for COVID-19, the company empowers people to learn about their health and make confident decisions. With this authorization, the company will help more people get tested, reduce the spread of the virus and improve the health of communities

The company has a wide presence across North America, Europe, Asia-Pacific, South America, and the Middle East, and Africa. The company has various subsidiaries such as Covance (U.S.), Pathology Associates Medical Laboratories (U.S.), Sequenom (U.S.), Medtox Laboratories, Inc (U.S.), and Esoterix Inc (U.S.), among others.

Siemens Healthcare GmbH

Siemens Healthcare GmbH has headquarters in Erlangen, Germany. It has public ownership. The company offers technologies and services in diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, and digital health and enterprise services. The company has various business segments such as Medical Imaging, Diagnostics, and Advanced Therapies, under which Diagnostics is the market-focused segment. The company has service categories such as Laboratory, Point-of-Care, and Molecular Diagnostics. The market-focused category is Laboratory Diagnostics.

For instance,

  • In June 2021, Siemens Healthcare GmbH and Prisma Health announced a strategic partnership to assist the South Carolina region in achieving better health. This valued partnership focuses on healthcare innovation, workforce development, and enhancing health care for Prisma Health's patients and communities

The company has a presence across North America, Asia-Pacific, Europe, South America, and the Middle East, and Africa. The company has initiated many strategic initiatives to expand its market.